Federal Capture Intelligence

Top DoD pharmaceutical preparation manufacturing contractors (NAICS 325412)

Contract actions: October 1, 2021 – September 10, 2026 Updated September 11, 2026 Department of Defense agency guide NAICS 325412 · Pharmaceutical Preparation Manufacturing
Latest 12 months
$57.4M
Net obligations · Down $45.6M vs. $103.0M preceding
Prime contractors
74
With positive obligations in the latest 12 months

Research the DoD federal contracting market for pharmaceutical preparation manufacturing under NAICS 325412. Compare top federal contractors and market share, reported contract obligations and spending trends, funding-office attribution, recent award activity, contract types, competition, and procurement methods, and observed contract vehicle usage.

Contract obligation trends for Pharmaceutical Preparation Manufacturing at the Department of Defense

Federal records show $26.3B in net obligations across 80,748 awards in Pharmaceutical Preparation Manufacturing at the Department of Defense from Oct 1, 2021 through Sep 10, 2026. This market accounts for 1.2% of $2.3T in agency-wide net prime contract obligations over the period shown. Latest 12-month net obligations decreased 44.3% from $103.0M to $57.4M. 7 prime contractors accounted for at least 80% of positive obligations in that latest period.

Fiscal-year activity

FY26 is year-to-date through Sep 10, 2026; earlier years show complete fiscal-year totals.

FY26 year-to-date: $54.0M versus $85.5M through the same date in FY25 (−36.8%).
Net obligations · complete fiscal yearNet obligations · FY26 YTDContract actions
View fiscal-year data table
Fiscal yearNet obligationsContract actionsCoverage
FY2022$24.0B18,496Complete
FY2023$2.0B16,837Complete
FY2024$116.4M17,387Complete
FY2025$88.9M23,693Complete
FY2026$54.0M9,117YTD through Sep 10, 2026

Market at a glance

All reported prime contract awards
All-period net obligations
$26.3B
80,748 awards · 218 prime contractors
Latest 12-month movement
−44.3%
$57.4M vs. $103.0M
Leading eight prime share
82.9%
Share held by the eight leading prime contractors in the latest 12 months
View agency share, denominators, and set-aside reporting
Agency context
1.2% of $2.3T in agency-wide net obligations.
Set-aside share when reported
0.9% of 11,784 awards with reported set-aside status.
Set-aside reporting
110 set aside · 11,674 no set-aside · 68,964 not reported

What changed in the last 12 months?

Sep 11, 2025–Sep 10, 2026, compared with Sep 11, 2024–Sep 10, 2025.

Competitive shifts

NOVARTIS PHARMACEUTICALS CORPORATION climbed the most in the contractor rankings
#24→#3Up 21 places
The contractor accounts for 7.5% of positive obligations across 6 reported actions.
TEVA PHARMACEUTICALS USA, INC. had the largest decline in reported obligations
$43.5M→$21.9M−$21.6M
The contractor now ranks #1 by positive obligations and accounts for 38.1% of positive obligations, based on 21 reported actions.
DMS PHARMACEUTICAL GROUP INC fell the most in the contractor rankings
#3→#27Down 24 places
The contractor accounts for 0.31% of positive obligations across 2,828 reported actions.

Buyer demand

Reported obligations through DLA TROOP SUPPORT decreased
$50.9M→$23.2M−$27.8M
Latest-period activity spans 3,608 awards across 33 prime contractors.
Reported obligations through AMC BAMC FSH - MM increased
$3.0M→$5.9M+$2.9M
Latest-period activity spans 21 awards across 14 prime contractors.
How these findings are calculated

Findings are selected from matched-period changes in obligations, share, rank, funding offices, concentration, reported set-asides, material award actions, and agency-peer outliers. Related signals are combined, and only material evidence-backed changes are shown. Review the full methodology.

Federal contract obligations by funding office

See how positive obligations were attributed across funding offices in the 12 months ending Sep 10, 2026.

40.3% of positive obligations were attributed to DLA TROOP SUPPORT (SPE2DP). That represents $23.2M, down $27.8M from the preceding 12 months.

Latest 12-month share of positive obligations; the gray segment represents all other reported offices.

  1. DLA TROOP SUPPORT (SPE2DP)40.3% · $23.2M · down $27.8M
  2. DLA TROOP SUPPORT (SPE2D6)22.1% · $12.7M · down $14.0M
  3. AMC BAMC FSH - MM10.2% · $5.9M · up $2.9M
  4. DLA TROOP SUPPORT (SPE2D0)4.1% · $2.4M · down $6K
  5. DIRECTOR, WRNMMC3.9% · $2.2M · down $584K
  6. All other reported offices19.3% of positive obligations
View reported office rankings, comparisons, and evidence

USAspending assigns each award to a funding office. That office may differ from the requiring activity, program office, contracting office, individual buyer, or actual customer.

  1. Reported funding office

    DLA TROOP SUPPORT (SPE2DP)

    #1Rank unchanged

    Latest 12 months

    $23.2M

    40.3% of positive obligations

    Versus preceding 12 months

    −$27.8M

    33 active prime contractors · 3,608 awards

    View office comparison and evidence

    Reported obligations decreased 54.5% from $50.9M to $23.2M. The office’s share of positive obligations moved from 49.4% to 40.3%, a change of −9.0 percentage points.

    The latest period contains 3,740 actions across 3,608 awards and 9 newly active prime contractors. The preceding period contained 36 active prime contractors and 15,983 awards.

    Leading award-level changes

  2. Reported funding office

    DLA TROOP SUPPORT (SPE2D6)

    #2Rank unchanged

    Latest 12 months

    $12.7M

    22.1% of positive obligations

    Versus preceding 12 months

    −$14.0M

    1 active prime contractor · 137 awards

    View office comparison and evidence

    Reported obligations decreased 52.4% from $26.7M to $12.7M. The office’s share of positive obligations moved from 25.9% to 22.1%, a change of −3.7 percentage points.

    The latest period contains 137 actions across 137 awards. The preceding period contained 1 active prime contractor and 192 awards.

  3. Reported funding office

    AMC BAMC FSH - MM

    #3Up 1 from #4

    Latest 12 months

    $5.9M

    10.2% of positive obligations

    Versus preceding 12 months

    +$2.9M

    14 active prime contractors · 21 awards

    View office comparison and evidence

    Reported obligations increased 97.5% from $3.0M to $5.9M. The office’s share of positive obligations moved from 2.9% to 10.2%, a change of +7.3 percentage points.

    The latest period contains 47 actions across 21 awards and 2 newly active prime contractors. The preceding period contained 17 active prime contractors and 22 awards.

    Leading award-level changes

  4. Reported funding office

    DLA TROOP SUPPORT (SPE2D0)

    #4Up 2 from #6

    Latest 12 months

    $2.4M

    4.1% of positive obligations

    Versus preceding 12 months

    −$6K

    5 active prime contractors · 26 awards

    View office comparison and evidence

    Reported obligations decreased 0.3% from $2.4M to $2.4M. The office’s share of positive obligations moved from 2.3% to 4.1%, a change of +1.8 percentage points.

    The latest period contains 26 actions across 26 awards and 2 newly active prime contractors. The preceding period contained 6 active prime contractors and 54 awards.

  5. Reported funding office

    DIRECTOR, WRNMMC

    #5Rank unchanged

    Latest 12 months

    $2.2M

    3.9% of positive obligations

    Versus preceding 12 months

    −$584K

    11 active prime contractors · 12 awards

    View office comparison and evidence

    Reported obligations decreased 20.7% from $2.8M to $2.2M. The office’s share of positive obligations moved from 2.7% to 3.9%, a change of +1.2 percentage points.

    The latest period contains 13 actions across 12 awards and 2 newly active prime contractors. The preceding period contained 11 active prime contractors and 17 awards.

  6. Reported funding office

    AMC BEAUMONT BLISS - MM

    #6Up 4 from #10

    Latest 12 months

    $2.1M

    3.7% of positive obligations

    Versus preceding 12 months

    +$1.1M

    8 active prime contractors · 9 awards

    View office comparison and evidence

    Reported obligations increased 111.5% from $1.0M to $2.1M. The office’s share of positive obligations moved from 0.98% to 3.7%, a change of +2.7 percentage points.

    The latest period contains 21 actions across 9 awards and 2 newly active prime contractors. The preceding period contained 8 active prime contractors and 8 awards.

  7. Reported funding office

    KIMBROUGH AMB CC MEADE - MM

    #7Rank unchanged

    Latest 12 months

    $1.2M

    2.0% of positive obligations

    Versus preceding 12 months

    −$895K

    2 active prime contractors · 3 awards

    View office comparison and evidence

    Reported obligations decreased 43.3% from $2.1M to $1.2M. The office’s share of positive obligations moved from 2.0% to 2.0%, a change of 0.0 percentage points.

    The latest period contains 4 actions across 3 awards. The preceding period contained 3 active prime contractors and 6 awards.

  8. Reported funding office

    NAV MED CNT PORTSMOUTH VA - MM

    #8Up 3 from #11

    Latest 12 months

    $1.0M

    1.8% of positive obligations

    Versus preceding 12 months

    +$65K

    4 active prime contractors · 5 awards

    View office comparison and evidence

    Reported obligations increased 6.6% from $983K to $1.0M. The office’s share of positive obligations moved from 0.95% to 1.8%, a change of +0.9 percentage points.

    The latest period contains 10 actions across 5 awards. The preceding period contained 4 active prime contractors and 5 awards.

  9. Reported funding office

    AMC TRIPLER SHAFTER - MM

    #9Up 4 from #13

    Latest 12 months

    $1.0M

    1.8% of positive obligations

    Versus preceding 12 months

    +$326K

    5 active prime contractors · 7 awards

    View office comparison and evidence

    Reported obligations increased 45.7% from $712K to $1.0M. The office’s share of positive obligations moved from 0.69% to 1.8%, a change of +1.1 percentage points.

    The latest period contains 20 actions across 7 awards and 1 newly active prime contractor. The preceding period contained 6 active prime contractors and 7 awards.

  10. Reported funding office

    DLA TROOP SUPPORT (SPE2D9)

    #10Down 2 from #8

    Latest 12 months

    $986K

    1.7% of positive obligations

    Versus preceding 12 months

    −$648K

    1 active prime contractor · 5,230 awards

    View office comparison and evidence

    Reported obligations decreased 39.6% from $1.6M to $986K. The office’s share of positive obligations moved from 1.6% to 1.7%, a change of +0.1 percentage points.

    The latest period contains 5,230 actions across 5,230 awards. The preceding period contained 1 active prime contractor and 4,690 awards.

  11. Reported funding office

    AMC GORDON - PB

    #11Up 10 from #21

    Latest 12 months

    $563K

    0.98% of positive obligations

    Versus preceding 12 months

    +$314K

    3 active prime contractors · 4 awards

    View office comparison and evidence

    Reported obligations increased 126.0% from $249K to $563K. The office’s share of positive obligations moved from 0.24% to 0.98%, a change of +0.7 percentage points.

    The latest period contains 6 actions across 4 awards. The preceding period contained 4 active prime contractors and 4 awards.

  12. Reported funding office

    NAV MED CTR SAN DIEGO CA - MM

    #12Up 25 from #37

    Latest 12 months

    $554K

    0.96% of positive obligations

    Versus preceding 12 months

    +$510K

    2 active prime contractors · 3 awards

    View office comparison and evidence

    Reported obligations increased 1168.2% from $44K to $554K. The office’s share of positive obligations moved from 0.040% to 0.96%, a change of +0.9 percentage points.

    The latest period contains 5 actions across 3 awards and 1 newly active prime contractor. The preceding period contained 1 active prime contractor and 3 awards.

  13. Reported funding office

    W6DZ CPE CBRND FT DETRICK

    No positive-obligation rank

    Latest 12 months

    $0

    0% of positive obligations

    Versus preceding 12 months

    −$1.2M

    0 active prime contractors · 0 awards

    View office comparison and evidence

    Reported obligations decreased 100.0% from $1.2M to $0. The office’s share of positive obligations moved from 1.2% to 0%, a change of −1.2 percentage points.

    The latest period contains 0 actions across 0 awards. The preceding period contained 2 active prime contractors and 2 awards.

  14. Reported funding office

    W2DN BROOKE AMC

    No positive-obligation rank

    Latest 12 months

    $0

    0% of positive obligations

    Versus preceding 12 months

    −$3.8M

    0 active prime contractors · 0 awards

    View office comparison and evidence

    Reported obligations decreased 100.0% from $3.8M to $0. The office’s share of positive obligations moved from 3.7% to 0%, a change of −3.7 percentage points.

    The latest period contains 0 actions across 0 awards. The preceding period contained 3 active prime contractors and 3 awards.

Contract types, competition, and procurement methods

From Sep 11, 2025 through Sep 10, 2026, 8,370 awards had positive obligations totaling $58.3M. Only One Source was the leading reported procedure, accounting for 66.0% of positive obligations. Awards with a reported parent IDV accounted for 82.9%. Reported awards used contract vehicles such as VA FSS Schedule 65IB.

Leading award type
79.5%
Delivery Order
Leading reported procedure
66.0%
Only One Source
Reported parent IDV
82.9%
of positive obligations had a reported parent IDV
Median reported offers
2
1,046 of 8,370 awards reported offers · Limited reporting

Observed contract vehicles

Only exact reported parent-PIID matches are shown; missing parent IDs are not inferred.

Same-NAICS comparison

Compared with the NAICS 325412 peer median, parent-IDV obligation share is 15.3 percentage points lower, reported full-and-open obligation share is 46.3 percentage points lower, delivery-order obligation share is 18.5 percentage points lower, and median positive award obligations are 99.9% lower.

MeasureThis marketPeer medianDifference
Parent-IDV obligation share82.9%98.2%-15.3 pts
Reported full-and-open obligation share10.1%56.4%-46.3 pts
Delivery-order obligation share79.5%98.0%-18.5 pts
Median positive award obligations$54$65K-99.9%
Peer cohort and comparison limits

The peer median gives each of the 3 eligible agency markets equal weight. The included agency markets are:

Agency mission, scale, and acquisition context can differ. Peer position does not establish market attractiveness or predict a future procurement method.

View buying-method details and data coverage

Award types

Reported valueAwardsPositive obligationsShare
Delivery Order(C)7,333$46.3M79.5%
Purchase Order(B)1,007$9.0M15.5%
BPA Call(A)27$2.0M3.4%
Definitive Contract(D)3$951K1.6%

Reported parent-award types

Reported valueAwardsPositive obligationsShare
IDC(B)7,323$45.4M77.8%
BPA(E)27$2.0M3.4%
FSS(C)10$961K1.6%
Not reported1,010$10.0M17.1%

Single- or multiple-award parent structure

Reported valueAwardsPositive obligationsShare
Single Award(S)7,350$47.3M81.2%
Multiple Award(M)10$961K1.6%
Not reported1,010$10.0M17.1%

Solicitation procedures

Reported valueAwardsPositive obligationsShare
Only One Source(SSS)166$38.5M66.0%
Simplified Acquisition(SP1)1,017$11.2M19.2%
Negotiated Proposal/Quote(NP)7,094$4.8M8.3%
Sss(ONLY ONE SOURCE)3$1.7M3.0%
Subject to Multiple Award Fair Opportunity(MAFO)11$1.2M2.1%
Np(NEGOTIATED PROPOSAL/QUOTE)30$804K1.4%
Other reported values49$17K0.029%

Extent competed

Reported valueAwardsPositive obligationsShare
Not Competed(C)32$27.4M47.1%
Not Available for Competition(B)134$11.0M18.9%
Full and Open Competition(A)7,104$5.9M10.1%
Not Competed Under SAP(G)83$5.7M9.9%
Competed Under SAP(F)934$5.5M9.4%
B(NOT AVAILABLE FOR COMPETITION)2$1.7M2.9%
Other reported values81$997K1.7%

Fair-opportunity and limited-source reporting

Reported valueAwardsPositive obligationsShare
Only One Source - Other(ONE)6$749K1.3%
Other Statutory Authority(OSA)1$245K0.42%
Fair Opportunity Given(FAIR)2$180K0.31%
FAR 16.505(B)(2)(I)(G) Single Source(SSRC)1$20K0.030%
FAR 16.505(B)(2)(I)(G) Limited Sources(LSRC)1$15K0.030%
Not reported8,359$57.1M97.9%

Other-than-full-and-open reasons

Reported valueAwardsPositive obligationsShare
Only One Source-Other (FAR 6.302-1 Other)(ONE)168$40.0M68.7%
SAP Non-Competition (FAR 13)(SP2)86$5.6M9.6%
Authorized by Statute (FAR 6.302-5(A)(2)(I))(OTH)1$182K0.31%
Unique Source (FAR 6.302-1(B)(1))(UNQ)1$177K0.30%
Not reported8,114$12.3M21.2%

Contract pricing types

Reported valueAwardsPositive obligationsShare
Firm Fixed Price(J)8,288$55.7M95.6%
J(FIRM FIXED PRICE)82$2.5M4.4%

Product or Service Codes

Reported valueAwardsPositive obligationsShare
Drugs and Biologicals(6505)8,073$53.5M91.9%
Medical and Surgical Instruments, Equipment, and Supplies(6515)67$1.4M2.4%
Laboratory Equipment and Supplies(6640)6$1.2M2.1%
in Vitro Diagnostic Substances, Reagents, Test Kits and Sets(6550)67$765K1.3%
Pharmacy Services(Q517)7$479K0.82%
Medical- Radiology(Q522)1$262K0.45%
Other reported values149$597K1.0%

Awarding subagencies

Reported valueAwardsPositive obligationsShare
Defense Logistics Agency(97AS)8,257$40.7M69.8%
Department of the Army(2100)61$11.6M19.9%
Defense Health Agency(97DH)46$5.8M9.9%
Department of the Air Force(5700)5$266K0.46%
U.S. Special Operations Command(97ZS)1$7K0.010%

Awarding offices

Reported valueAwardsPositive obligationsShare
Dla Troop Support(SPE2DP)1,993$24.0M41.2%
Dla Troop Support(SPE2D6)136$12.7M21.9%
W40m Mrc0 West(W81K00)39$9.3M16.0%
Dla Troop Support(SPE2D0)4$2.4M4.1%
Defense Health Agency(HT0014)12$2.3M3.9%
Defense Health Agency Hcd West(HT9410)12$1.8M3.1%
Other reported values6,174$5.7M9.8%

Reported parent IDVs

Reported valueAwardsPositive obligationsShare
SPE2DP20D0002(9700)21$21.9M37.6%
SPE2DP23D0001(9700)136$12.7M21.9%
W81K0024D0004(9700)1$3.2M5.5%
SPE2D021D0008(9700)27$1.8M3.1%
SPE2DP21D0002(9700)3$1.2M2.1%
SPE2DX25D8022(9700)4,930$986K1.7%
HT940625D0001(9700)2$530K0.91%
SPE2DX15D9383(9700)1,102$484K0.83%
Other reported values1,138$5.4M9.3%
Not reported1,010$10.0M17.1%

Exact vehicle-match evidence

Reported award data linked 1 award to a specific catalog vehicle.

Offers, award size, and timing

Median reported offers
2 median
1,046 reported · 7,324 not reported · Limited reporting
Positive award obligations
$54 median
$17–$205 middle 50%
Reported performance period
0 days median
8,370 reported · 0 not reported
Zero days means the reported start and current-end dates were the same.

Calculations group latest-period actions by award, retain awards with positive net obligations for share denominators, and use each award's latest reported USAspending procurement fields as of Sep 10, 2026. Blank competition, pricing, PSC, or parent-IDV values remain not reported; they are not inferred. Offer counts must be positive and below the FPDS 999 placeholder. Awarding organizations can differ from the funding agency that defines this page.

Top federal contractors

Latest 12-month market share, concentration, and complete prime contractor rankings across the period shown.

Prime contractor concentration
7 of 74prime contractors account for at least 80% of positive obligations in the last 12 months
Largest prime contractor
38.1%of positive obligations in the last 12 months
Leading four prime contractors
74.2%of positive obligations in the last 12 months
Leading eight prime contractors
82.9%of positive obligations in the last 12 months

Based on $57.5M in positive obligations during the 12 months ending Sep 10, 2026. Individual shares and movement appear in the searchable rankings below. Movement compares with Sep 11, 2024–Sep 10, 2025.

Last 12mo obligation volume: Highest positive obligations first; net deobligations follow by magnitude; contractors with no activity in the last 12 months follow by all-period obligations. Ranks use the complete contractor list and remain fixed when search narrows the results.

15 leading contractors
  1. #1

    Last 12mo obligations

    $21.9M

    38.1%

    Dollar movement

    −$21.6M

    vs. prior 12 months

    Last 12mo awards

    21 awards

    21 actions

    Historical and award details for TEVA PHARMACEUTICALS USA, INC.
    Obligations: prior → latest
    $43.5M → $21.9M
    −49.6%
    Share: prior → latest
    42.1% → 38.1%
    −3.9 percentage points
    All-period obligations
    $172.4M
    0.66% of all-period positive obligations · 332 awards
    Recorded activity
    Since Nov 9, 2021
    through Apr 15, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside01
    Not reported2174
    Reported small business00
    All-period set-aside types

    None reported.

  2. #2

    Last 12mo obligations

    $13.8M

    23.9%

    Dollar movement

    −$13.9M

    vs. prior 12 months

    Last 12mo awards

    141 awards

    141 actions

    Historical and award details for CANADIAN COMMERCIAL CORPORATION
    Obligations: prior → latest
    $27.6M → $13.8M
    −50.2%
    Share: prior → latest
    26.7% → 23.9%
    −2.8 percentage points
    All-period obligations
    $112.6M
    0.43% of all-period positive obligations · 1,038 awards
    Recorded activity
    Since Oct 6, 2021
    through May 18, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside00
    Not reported141195
    Reported small business00
    All-period set-aside types

    None reported.

  3. #3

    Last 12mo obligations

    $4.3M

    7.5%

    Dollar movement

    +$3.9M

    vs. prior 12 months

    Last 12mo awards

    4 awards

    6 actions

    Historical and award details for NOVARTIS PHARMACEUTICALS CORPORATION
    Obligations: prior → latest
    $426K → $4.3M
    +907.5%
    Share: prior → latest
    0.41% → 7.5%
    +7.1 percentage points
    All-period obligations
    $4.7M
    0.020% of all-period positive obligations · 6 awards
    Recorded activity
    Since Jul 1, 2025
    through Feb 11, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside21
    Not reported22
    Reported small business00
    All-period set-aside types

    None reported.

  4. #4

    Last 12mo obligations

    $2.7M

    4.6%

    Dollar movement

    −$544K

    vs. prior 12 months

    Last 12mo awards

    19 awards

    30 actions

    Historical and award details for CARDINAL HEALTH 414, LLC
    Obligations: prior → latest
    $3.2M → $2.7M
    −17.0%
    Share: prior → latest
    3.1% → 4.6%
    +1.5 percentage points
    All-period obligations
    $14.5M
    0.060% of all-period positive obligations · 77 awards
    Recorded activity
    Since Oct 6, 2021
    through Apr 20, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside1312
    Not reported63
    Reported small business00
    All-period set-aside types

    None reported.

  5. #5

    Last 12mo obligations

    $1.8M

    3.1%

    Dollar movement

    +$1.2M

    vs. prior 12 months

    Last 12mo awards

    27 awards

    27 actions

    Historical and award details for AMERICAN REGENT INC
    Obligations: prior → latest
    $642K → $1.8M
    +179.4%
    Share: prior → latest
    0.62% → 3.1%
    +2.5 percentage points
    All-period obligations
    $3.6M
    0.010% of all-period positive obligations · 154 awards
    Recorded activity
    Since Mar 28, 2022
    through Apr 14, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside00
    Not reported2745
    Reported small business00
    All-period set-aside types

    None reported.

  6. #6

    Last 12mo obligations

    $1.2M

    2.0%

    Dollar movement

    +$108K

    vs. prior 12 months

    Last 12mo awards

    1 award

    2 actions

    Historical and award details for JUBILANT HOLLISTERSTIER LLC
    Obligations: prior → latest
    $1.0M → $1.2M
    +10.3%
    Share: prior → latest
    1.0% → 2.0%
    +1.0 percentage points
    All-period obligations
    $3.1M
    0.010% of all-period positive obligations · 1 award
    Recorded activity
    Since Sep 29, 2023
    through Apr 9, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside11
    Not reported00
    Reported small business00
    All-period set-aside types

    None reported.

  7. #7

    Last 12mo obligations

    $1.1M

    1.8%

    Dollar movement

    +$372K

    vs. prior 12 months

    Last 12mo awards

    6 awards

    14 actions

    Historical and award details for LANTHEUS MEDICAL IMAGING, INC.
    Obligations: prior → latest
    $683K → $1.1M
    +54.5%
    Share: prior → latest
    0.66% → 1.8%
    +1.2 percentage points
    All-period obligations
    $4.3M
    0.020% of all-period positive obligations · 32 awards
    Recorded activity
    Since Oct 7, 2021
    through Apr 16, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside21
    Reported no set-aside23
    Not reported22
    Reported small business54
    All-period set-aside types
    • 3 · Total small business
  8. #8

    Last 12mo obligations

    $986K

    1.7%

    Dollar movement

    −$648K

    vs. prior 12 months

    Last 12mo awards

    5,230 awards

    5,230 actions

    Historical and award details for CARDINAL HEALTH, INC.
    Obligations: prior → latest
    $1.6M → $986K
    −39.6%
    Share: prior → latest
    1.6% → 1.7%
    +0.1 percentage points
    All-period obligations
    $7.5M
    0.030% of all-period positive obligations · 24,572 awards
    Recorded activity
    Since Oct 1, 2021
    through May 27, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside00
    Not reported5,2304,690
    Reported small business00
    All-period set-aside types

    None reported.

  9. #9

    Last 12mo obligations

    $883K

    1.5%

    Dollar movement

    +$451K

    vs. prior 12 months

    Last 12mo awards

    2 awards

    3 actions

    Historical and award details for BRACCO DIAGNOSTICS INC.
    Obligations: prior → latest
    $432K → $883K
    +104.2%
    Share: prior → latest
    0.42% → 1.5%
    +1.1 percentage points
    All-period obligations
    $1.7M
    0.010% of all-period positive obligations · 6 awards
    Recorded activity
    Since Dec 15, 2021
    through Dec 15, 2025

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside23
    Not reported00
    Reported small business00
    All-period set-aside types

    None reported.

  10. #10

    Last 12mo obligations

    $882K

    1.5%

    Dollar movement

    +$132K

    vs. prior 12 months

    Last 12mo awards

    8 awards

    18 actions

    Historical and award details for PETNET SOLUTIONS, INC.
    Obligations: prior → latest
    $751K → $882K
    +17.6%
    Share: prior → latest
    0.73% → 1.5%
    +0.8 percentage points
    All-period obligations
    $3.2M
    0.010% of all-period positive obligations · 26 awards
    Recorded activity
    Since Oct 1, 2021
    through Apr 3, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside84
    Not reported00
    Reported small business00
    All-period set-aside types

    None reported.

  11. #11

    Last 12mo obligations

    $802K

    1.4%

    Dollar movement

    −$518K

    vs. prior 12 months

    Last 12mo awards

    5 awards

    13 actions

    Historical and award details for BOSTON SCIENTIFIC CORP
    Obligations: prior → latest
    $1.3M → $802K
    −39.3%
    Share: prior → latest
    1.3% → 1.4%
    +0.1 percentage points
    All-period obligations
    $4.0M
    0.020% of all-period positive obligations · 19 awards
    Recorded activity
    Since Oct 27, 2021
    through Apr 8, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside32
    Not reported22
    Reported small business00
    All-period set-aside types

    None reported.

  12. #12

    Last 12mo obligations

    $593K

    1.0%

    Dollar movement

    +$205K

    vs. prior 12 months

    Last 12mo awards

    1 award

    3 actions

    Historical and award details for HAMAMATSU/QUEEN'S PET IMAGING CENTER, LLC
    Obligations: prior → latest
    $388K → $593K
    +52.7%
    Share: prior → latest
    0.38% → 1.0%
    +0.7 percentage points
    All-period obligations
    $981K
    0% of all-period positive obligations · 1 award
    Recorded activity
    Since Sep 23, 2024
    through Apr 2, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside11
    Not reported00
    Reported small business11
    All-period set-aside types

    None reported.

  13. #13

    Last 12mo obligations

    $532K

    0.93%

    Dollar movement

    −$626K

    vs. prior 12 months

    Last 12mo awards

    6 awards

    8 actions

    Historical and award details for SOFIE CO.
    Obligations: prior → latest
    $1.2M → $532K
    −54.1%
    Share: prior → latest
    1.1% → 0.93%
    −0.2 percentage points
    All-period obligations
    $4.3M
    0.020% of all-period positive obligations · 57 awards
    Recorded activity
    Since Oct 1, 2021
    through Feb 4, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside612
    Not reported00
    Reported small business01
    All-period set-aside types

    None reported.

  14. #14

    Last 12mo obligations

    $531K

    0.92%

    Dollar movement

    +$101K

    vs. prior 12 months

    Last 12mo awards

    3 awards

    7 actions

    Historical and award details for AMERICAN NATIONAL SERVICES LLC
    Obligations: prior → latest
    $429K → $531K
    +23.6%
    Share: prior → latest
    0.42% → 0.92%
    +0.5 percentage points
    All-period obligations
    $2.5M
    0.010% of all-period positive obligations · 9 awards
    Recorded activity
    Since Nov 5, 2021
    through Apr 6, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside21
    Reported no set-aside00
    Not reported11
    Reported small business32
    All-period set-aside types
    • 2 · Total small business
  15. #15

    Last 12mo obligations

    $496K

    0.86%

    Dollar movement

    −$169K

    vs. prior 12 months

    Last 12mo awards

    8 awards

    21 actions

    Historical and award details for INO THERAPEUTICS LLC
    Obligations: prior → latest
    $665K → $496K
    −25.4%
    Share: prior → latest
    0.64% → 0.86%
    +0.2 percentage points
    All-period obligations
    $3.3M
    0.010% of all-period positive obligations · 23 awards
    Recorded activity
    Since Oct 18, 2021
    through Apr 15, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside24
    Not reported66
    Reported small business00
    All-period set-aside types

    None reported.

Recent federal contract award activity

Recent contract actions with unusually large obligation changes or meaningful shifts in contractor and funding-office activity.

Modification

This action

+$3.2M

NOVARTIS PHARMACEUTICALS CORPORATION

AMC BAMC FSH - MM

LUTATHERA AND PLUVICTO - FY26 FUNDING FOR CLINS 0001 AND 0002 FOR POP DATE FROM 1OCT25 TO 30 SEPT 26.

Why it stands out

The contractor climbed 21 positions in this market.

It now ranks #3 by positive obligations over the latest 12 months.

Award net obligations
$3.2M
Share of 12-month positive obligations
5.5%
Supporting data
Prime contractor
#3 · 7.5% share
up 21 ranks · +7.1 percentage points · $3.9M net increase; action accounted for 82.1%
Funding office
#3 · 10.2% attributed share
up 1 rank · +7.3 percentage points · $2.9M net increase; action exceeded it by $278K
Related:Largest rank gainFunding office gain
PIID W81K0025FA195 · Mod P00002
Base award

This action

+$5.2M

CANADIAN COMMERCIAL CORPORATION

DLA TROOP SUPPORT

4571290114!REACTIVE SKIN DECONTAMINATION LOTION

Why it stands out

A new award added obligations despite weaker contractor activity.

The action represented 9.0% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $13.9M overall.

Award net obligations
$5.2M
Share of 12-month positive obligations
9.0%
Supporting data
Prime contractor
#2 · 23.9% share
$13.9M net decline despite this positive action
Funding office
#2 · 22.1% attributed share
$14.0M net decline despite this positive action
PIID SPE2D626F6F83
Base award

This action

+$4.0M

TEVA PHARMACEUTICALS USA, INC.

DLA TROOP SUPPORT

8511984334!ADENOVIRUS TYPE 4 A

Why it stands out

A new award added obligations despite weaker contractor activity.

The action represented 6.9% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $21.6M overall.

Award net obligations
$4.0M
Share of 12-month positive obligations
6.9%
Supporting data
Prime contractor
#1 · 38.1% share
$21.6M net decline despite this positive action
Funding office
#1 · 40.3% attributed share
$27.8M net decline despite this positive action
PIID SPE2DP26F3586
Base award

This action

+$1.8M

AMERICAN REGENT INC

DLA TROOP SUPPORT

8511647514!OTHER MEDICAL

Why it stands out

The contractor climbed 15 positions in this market.

It now ranks #5 by positive obligations over the latest 12 months.

Award net obligations
$1.8M
Share of 12-month positive obligations
3.1%
Supporting data
Prime contractor
#5 · 3.1% share
up 15 ranks · +2.5 percentage points · $1.2M net increase; action exceeded it by $625K
Funding office
#4 · 4.1% attributed share
$6K net decline despite this positive action
PIID SPE2D025F0681
Modification

This action

+$864K

JUBILANT HOLLISTERSTIER LLC

KIMBROUGH AMB CC MEADE - MM

ANTIVENOM IMMUNOTHERAPY SUPPLIES

Why it stands out

This award grew while spending attributed to its office declined.

The modification added $864K while office-attributed obligations fell $895K overall.

Award net obligations
$3.1M
Share of 12-month positive obligations
1.5%
Supporting data
Funding office
#7 · 2.0% attributed share
$895K net decline despite this positive action
PIID W91YTZ23P0137 · Mod P00008
Modification

This action

+$525K

CARDINAL HEALTH 414, LLC

AMC BRAGG - MM

OPTION YEAR FOUR (4)

Why it stands out

This award grew while spending attributed to its office declined.

The modification added $525K while office-attributed obligations fell $200K overall.

Award net obligations
$1.7M
Share of 12-month positive obligations
0.91%
Supporting data
Prime contractor
#4 · 4.6% share
$544K net decline despite this positive action
Funding office
#15 · 0.50% attributed share
$200K net decline despite this positive action
PIID W91YTZ21P0135 · Mod P00014
View recent award activity by date (10)
  1. MR UNLIMITED, LLCBase award · PIID SPE2DP26V0753
    Action+$166
    Award net obligations$166
  2. CARDINAL HEALTH, INC.Base award · PIID SPE2D926F6158
    Action+$55
    Award net obligations$55
  3. CARDINAL HEALTH, INC.Base award · PIID SPE2D926F6160
    Action+$55
    Award net obligations$55
  4. CARDINAL HEALTH, INC.Base award · PIID SPE2D926F6140
    Action+$27
    Award net obligations$27
  5. CARDINAL HEALTH, INC.Base award · PIID SPE2D926F6159
    Action+$27
    Award net obligations$27
  6. CARDINAL HEALTH, INC.Base award · PIID SPE2D926F6142
    Action+$16
    Award net obligations$16
  7. CARDINAL HEALTH, INC.Base award · PIID SPE2D926F6143
    Action+$16
    Award net obligations$16
  8. CARDINAL HEALTH, INC.Base award · PIID SPE2D926F6157
    Action+$16
    Award net obligations$16
  9. COVETRUS NORTH AMERICA, LLCBase award · PIID SPE2DP26P0863
    Action+$1K
    Award net obligations$1K
  10. CARDINAL HEALTH, INC.Base award · PIID SPE2D926F6063
    Action+$55
    Award net obligations$55

DoD pharmaceutical preparation manufacturing market FAQs

Answers based on reported federal contract data.

Who are the top DoD pharmaceutical preparation manufacturing contractors?

In the 12 months through September 10, 2026, TEVA PHARMACEUTICALS USA, INC., CANADIAN COMMERCIAL CORPORATION, and NOVARTIS PHARMACEUTICALS CORPORATION were the leading DoD pharmaceutical preparation manufacturing prime contractors by positive obligations.

  1. #1

    TEVA PHARMACEUTICALS USA, INC.

    $21,926,233 in positive obligations

  2. #2

    CANADIAN COMMERCIAL CORPORATION

    $13,761,344 in positive obligations

  3. #3

    NOVARTIS PHARMACEUTICALS CORPORATION

    $4,292,412 in positive obligations

Rankings use reported USAspending award data.

Did DoD contract obligations decrease in the pharmaceutical preparation manufacturing market?

Yes. Measured by net prime contract obligations, reported DoD activity in the pharmaceutical preparation manufacturing market decreased 44.3% from $103,045,102 in the preceding 12 months to $57,425,878 in the 12 months through September 10, 2026.

Latest 12 months
$57,425,878
Net prime contract obligations
Preceding 12 months
$103,045,102
Net prime contract obligations
Change
−44.3%
Between matched 12-month periods

Reported contract actions, not outlays or a forecast.

What recent DoD contract award activity was reported in the pharmaceutical preparation manufacturing market?

Recent DoD contract award activity reported in the pharmaceutical preparation manufacturing market included actions for NOVARTIS PHARMACEUTICALS CORPORATION, CANADIAN COMMERCIAL CORPORATION, and TEVA PHARMACEUTICALS USA, INC. during the 12 months through September 10, 2026.

Action obligations are transaction-level amounts, not current award-level obligations.

Which procurement methods were reported for DoD contracts under NAICS 325412?

From September 11, 2025 through September 10, 2026, DoD reported 8,370 positive-obligation awards for pharmaceutical preparation manufacturing under NAICS 325412. The leading award type was delivery order. The leading reported procedure was only one source.

Positive-obligation awards
8,370
Leading reported procedure
Only One Source
66% of positive obligations
Leading award type
Delivery Order
79.5% of positive obligations
Full and open
10.1%
of positive obligations
Reported parent IDV
82.9%
of positive obligations
Observed vehicles
VA FSS Schedule 65IB
Exact matches from reported parent PIIDs

Percentages use positive obligations as the denominator.

Apply this research to a live pursuit

Sweetspot connects opportunity qualification, competitive research, capture, and proposal work in one workspace.

See Sweetspot in action

Related market research

Complete market indexes:

Same NAICS at other agencies:

Nearby NAICS at this agency:

Markets sharing leading prime records:

Leading-prime vehicle memberships:

Company memberships do not establish award-channel use.

Reported obligations include contract actions from October 1, 2021 through September 10, 2026. Set-aside and business-size fields reflect award records, not a contractor's current eligibility. Public Department of Defense award records are generally delayed by 90 days.

Review data methodology